Clinical trial NCT03096119: A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Official title: A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hypertension
Keywords: blood pressure monitoring, home
Asia
Lead sponsor: Jichi Medical University
Sponsor class: OTHER
First posted: 2017-03-30
Enrollment: 1462
Sex: ALL
Minimum age (years): 20
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Inclusion criteria:

1. Age \>= 20 years
2. Subjects with stable medication (\> 3 months) diagnosed as hypertension
3. Asian
4. Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.

Brief summary: Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Detailed description: Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

The main purpose of this study is to:

* Assess HBP control status in each Asian country
* Develop an Asian consensus and Asia-specific treatment for hypertension
* Improve the management of hypertension in Asia by encouraging patients to monitor HBP

Eligibility criteria: Inclusion Criteria:

1. Age \>= 20 years
2. Subjects with stable medication (\> 3 months) diagnosed as hypertension
3. Asian
4. Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.

Exclusion Criteria:

-

Primary outcomes:
measure: Distribution rate based on the home BP of the patients.
timeFrame: 7 days or more blood pressure measurement
Secondary outcomes:
Other outcomes:
Locations:
city: Tochigi
country: Japan
facility: Jichi Medical University
Study officials:
affiliation: Jichi Medical University School of Medicine
name: Kazuomi Kario, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Chia YC, Kario K, Tomitani N, Park S, Shin J, Turana Y, Tay JC, Buranakitjaroen P, Chen CH, Hoshide S, Nailes J, Minh HV, Siddique S, Sison J, Soenarta AA, Sogunuru GP, Sukonthasarn A, Teo BW, Verma N, Zhang Y, Wang TD, Wang JG. Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study. J Clin Hypertens (Greenwich). 2020 Mar;22(3):407-414. doi: 10.1111/jch.13731. Epub 2019 Dec 31.